-
EASE OF USE OF TIRZEPATIDE: RESULTS FROM A US SURVEY OF INDIVIDUALS WITH OBESITY OR OVERWEIGHT
Mar 18, 2026, 21:38 PM -
UTILIZATION OF TARLATAMAB AND ASSOCIATED HEALTHCARE RESOURCE USE, COSTS, AND ADVERSE EVENTS: A RETROSPECTIVE COHORT STUDY USING A LARGE U.S. HOSPITAL DATABASE
Mar 18, 2026, 21:38 PM -
ALIGNING INNOVATION, IMPLEMENTATION, PATIENT VOICE, INSTITUTIONAL TIMELINES, AND CONTINUITY IN UHC-ALIGNED POPULATION SCREENING
Mar 18, 2026, 21:38 PM -
SYNTHETIC PROGRESSION-FREE SURVIVAL DATA GENERATION FROM PUBLISHED AGGREGATE TRIAL DATA
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF OCTOCOG ALFA VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS IN CENTRAL AMERICA, ECUADOR AND PERÚ
Mar 18, 2026, 21:38 PM -
DIRECT MEDICAL COSTS SAVED BY EARLY PAH DETECTION USING A MACHINE LEARNING ALGORITHM
Mar 18, 2026, 21:38 PM -
SOCIOECONOMIC STATUS AND SELF-RATED HEALTH IN KOREA AND JAPAN: A META-REGRESSION OF INCOME AND EDUCATION EFFECTS
Mar 18, 2026, 21:38 PM -
DOES LONG-TERM EXPOSURE TO OPIOID LEAD TO HIGHER RISK OF BREAST CANCER RECURRENCE? AN OBSERVATIONAL STUDY USING U.S. POPULATION DATA
Mar 18, 2026, 21:38 PM -
PREVALENCE OF DEPRESSION AMONG ADULTS WITH SICKLE CELL DISEASE IN TEXAS MEDICAID
Mar 18, 2026, 21:38 PM -
DISCHARGE DISPOSITION AND NEED FOR ONGOING CARE FOLLOWING HOSPITALIZATION OF HIGH-RISK PATIENTS WITH HOSPITALACQUIREDPRESSURE INJURIES(HAPIS)
Mar 18, 2026, 21:38 PM -
PREDICTING BIRTH TRENDS IN COLOMBIA POST-COVID-19 USING TIME SERIES MODELS
Mar 18, 2026, 21:38 PM -
IMPACT OF THE NUMBER OF TREATED VERTEBRAE ON THE SAFETY AND EFFICACY OUTCOMES OF VERTEBROPLASTY AND KYPHOPLASTY; SYSTEMATIC REVIEWS TO SUPPORT THE INDICATION EXPANSION OF THESE PROCEDURES FROM SINGLE-LEVEL TO MULTI-LEVEL FRACTURES IN JAPAN
Mar 18, 2026, 21:38 PM -
REAL-WORLD EPIDEMIOLOGY, CLINICAL OUTCOMES AND PATIENT SATISFACTION AMONG USERS OF ARTIFICIAL PANCREAS SYSTEMS IN TYPE 1 AND TYPE 2 DIABETES INSIGHTS FROM PHYSICIAN NOTES USING NLP
Mar 18, 2026, 21:38 PM -
PATIENT DESCRIPTIONS OF THE BENEFITS OF A REDUCED CORNSTARCH DOSE REGIMEN IN A PHASE 3 TRIAL OF DTX401 FOR GLYCOGEN STORAGE DISEASE TYPE IA
Mar 18, 2026, 21:38 PM -
GLOBAL LANDSCAPE OF ARTIFICIAL INTELLIGENCE IN HEALTH TECHNOLOGY ASSESSMENT: TRENDS, GOVERNANCE, AND EMERGING PRACTICES
Mar 18, 2026, 21:38 PM -
AUTOMATED STUDY FEASIBILITY USING AGENTIC ARTIFICIAL INTELLIGENCE TO RAPIDLY IDENTIFY FIT-FOR-PURPOSE SECONDARY DATA
Mar 18, 2026, 21:38 PM -
SOCIAL DETERMINANTS OF HEALTH AND GLP-1 PRESCRIBING PATTERNS IN T2D AND OBESITY: REAL-WORLD EVIDENCE FROM A LARGE, NATIONAL U.S. LINKED EHR-CLAIMS NETWORK
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A PROFESSIONAL FRAMEWORK FOR MARKET ACCESS WITHIN THE PHARMACEUTICAL INDUSTRY: A MULTI-METHODS STUDY
Mar 18, 2026, 21:38 PM -
EXPLORING POTENTIAL INTERACTIONS BETWEEN STATINS AND COVID-19 MEDICATIONS
Mar 18, 2026, 21:38 PM -
UTILIZATION OF BONE DENSITY TESTING IN RELATION TO SCREENING MAMMOGRAPHY AMONG COMMERCIALLY INSURED WOMEN: A DESCRIPTIVE ANALYSIS USING MARKETSCAN TREATMENT PATHWAYS
Mar 18, 2026, 21:38 PM
